Eight cycles of CHOP or R-CHOP chemotherapy were previously used for the treatment of aggressive lymphoma; the number of cycles was reduced to 6 based on the findings of RICOVER-60, which compared 6 and 8 cycles of biweekly CHOP with or without rituximab [9]. Here, DDIT3 is linked to lymphoma.